4958 second helical domain in RNA-polymerase beta-prime subunit
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 7 | 6.8 | 1.03× | q = 1.00 | |
| Benzenoids | 4 | 1.0 | 3.96× | not tested | |
| Organic oxygen compounds | 5 | 2.8 | 1.82× | not tested | |
| Organoheterocyclic compounds | 3 | 2.1 | 1.41× | not tested | |
| Organic acids and derivatives | 3 | 2.1 | 1.41× | not tested | |
| Nucleosides, nucleotides, and analogues | 5 | 3.8 | 1.31× | not tested | |
| Homogeneous non-metal compounds | 3 | 3.0 | 1.01× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02596 | APC | alpha,beta-Methyleneadenosine 5'-triphosphate | 11 |
| DB02431 | CTP | Cytidine-5'-Triphosphate | 10 |
| DB03532 | G2P | Phosphomethylphosphonic acid guanylate ester | 8 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 8 |
| DB04005 | UTP | Uridine 5'-triphosphate | 7 |
| DB00171 | ATP | ATP | 6 |
| DB04785 | STD | Streptolydigin | 6 |
| DB04022 | G4P | Guanosine tetraphosphate | 5 |
| DB04160 | PPV | Pyrophosphoric acid | 3 |
| DB00142 | GLU | Glutamic acid | 2 |
| DB02333 | DUT | Deoxyuridine-5'-Triphosphate | 2 |
| DB04788 | TGT | Tagetitoxin | 2 |
| DB08226 | MXP | Myxopyronin B | 2 |
| DB08266 | NE6 | Methyl [(1E,5R)-5-{3-[(2E,4E)-2,5-dimethyl-2,4-octadienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate | 2 |
| DB02181 | DGT | 2'-Deoxyguanosine-5'-Triphosphate | 1 |
| DB03258 | DCP | 2'-Deoxycytidine 5'-triphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 86 |
| MGmetal | MAGNESIUM ION | 24 |
| POP | PYROPHOSPHATE 2- | 11 |
| APC | DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER | 10 |
| W0F | [[(2~{S},3~{R},4~{S},5~{R})-5-(2-azanyl-6-oxidanylidene-3~{H}-purin-9-yl)-3-methoxy-4-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate | 10 |
| GTP | GUANOSINE-5'-TRIPHOSPHATE | 9 |
| 2TM | 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]methyl}phosphoryl]cytidine | 8 |
| ATP | ADENOSINE-5'-TRIPHOSPHATE | 7 |
| DPO | DIPHOSPHATE | 7 |
| G4P | GUANOSINE-5',3'-TETRAPHOSPHATE | 6 |
| STD | STREPTOLYDIGIN | 6 |
| CTP | CYTIDINE-5'-TRIPHOSPHATE | 5 |
| PPV | PYROPHOSPHATE | 4 |
| G2P | PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER | 3 |
| NE6 | methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate | 3 |
| UTP | URIDINE 5'-TRIPHOSPHATE | 3 |
| 2KH | 5'-O-[(S)-hydroxy{[(S)-hydroxy(phosphonooxy)phosphoryl]amino}phosphoryl]uridine | 2 |
| 42S | N'-hydroxy-N-phenyl-3-(trifluoromethyl)benzenecarboximidamide | 2 |
| 42T | 3-{[(2,6-dichlorophenyl)carbamoyl]amino}-N-hydroxy-N'-phenyl-5-(trifluoromethyl)benzenecarboximidamide | 2 |
| 42U | 4-[3-(4-fluorophenyl)-1H-pyrazol-4-yl]-N-[2-(piperazin-1-yl)ethyl]-2-(trifluoromethyl)aniline | 2 |